A 62-year-old man with T2D and macroalbuminuria (UACR 420 mg/g) despite ACE inhibitor asks about additional therapy to reduce progression and CV risk....

Question

A 62-year-old man with T2D and macroalbuminuria (UACR 420 mg/g) despite ACE inhibitor asks about additional therapy to reduce progression and CV risk. Which class is recommended next?

Accepted Answer

SGLT2 inhibitor (if not already) and consider nonsteroidal MRA (finerenone)

Answer

Thiazide diuretic

Answer

DPP‑4 inhibitor

Answer

Alpha-glucosidase inhibitor

Answer

Meglitinide

us-abim MCQ (SBA): Diabetic CKD-Finerenone Add-on

A 62-year-old man with T2D and macroalbuminuria (UACR 420 mg/g) despite ACE inhibitor asks about additional therapy to reduce progression and CV risk. Which class is recommended next?